Cargando…

Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE‐PD)

BACKGROUND: The immune system is a promising therapeutic target for disease modification in Parkinson's disease (PD), but appropriate immune‐related biomarkers must be identified to allow patient stratification for trials and tracking of therapeutic effects. The objective of this study was to i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams‐Gray, Caroline H., Wijeyekoon, Ruwani, Yarnall, Alison J., Lawson, Rachael A., Breen, David P., Evans, Jonathan R., Cummins, Gemma A., Duncan, Gordon W., Khoo, Tien K., Burn, David J., Barker, Roger A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957620/ https://www.ncbi.nlm.nih.gov/pubmed/26999434 http://dx.doi.org/10.1002/mds.26563

Ejemplares similares

Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson’s Disease in the ICICLE-PD Cohort
por: Lawson, Rachael A., et al.
Publicado: (2021)

Senescence and Inflammatory Markers for Predicting Clinical Progression in Parkinson’s Disease: The ICICLE-PD Study
por: Martin-Ruiz, Carmen, et al.
Publicado: (2020)

Progression of Neuropsychiatric Symptoms over Time in an Incident Parkinson’s Disease Cohort (ICICLE-PD)
por: Dlay, J. K., et al.
Publicado: (2020)

Baseline and longitudinal grey matter changes in newly diagnosed Parkinson’s disease: ICICLE-PD study
por: Mak, Elijah, et al.
Publicado: (2015)

Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD study
por: Nombela, Cristina, et al.
Publicado: (2014)

Trajectories of pain over 6 years in early Parkinson’s disease: ICICLE-PD
por: Naisby, J., et al.
Publicado: (2021)

Stability of mild cognitive impairment in newly diagnosed Parkinson's disease
por: Lawson, Rachael A, et al.
Publicado: (2017)

Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease
por: Dissanayaka, Nadeeka N.W., et al.
Publicado: (2017)

Cognitive decline and quality of life in incident Parkinson's disease: The role of attention
por: Lawson, Rachael A., et al.
Publicado: (2016)

Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life
por: Lawson, Rachael A., et al.
Publicado: (2014)

Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson’s Disease
por: Sleeman, Isobel, et al.
Publicado: (2019)

The Role of Vitamin D in Disease Progression in Early Parkinson’s Disease
por: Sleeman, Isobel, et al.
Publicado: (2017)

Cerebrospinal Fluid Cytokines and Neurodegeneration‐Associated Proteins in Parkinson's Disease
por: Wijeyekoon, Ruwani S., et al.
Publicado: (2020)

Gait Rather Than Cognition Predicts Decline in Specific Cognitive Domains in Early Parkinson’s Disease
por: Morris, Rosie, et al.
Publicado: (2017)

The Current Status of Neural Grafting in the Treatment of Huntington’s Disease. A Review
por: Wijeyekoon, Ruwani, et al.
Publicado: (2011)

Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease
por: Mak, Elijah, et al.
Publicado: (2017)

Identifying delirium in Parkinson disease: A pilot study
por: Lawson, Rachael A., et al.
Publicado: (2020)

Cognitive impairment in Parkinson's disease: impact on quality of life of carers
por: Lawson, RA, et al.
Publicado: (2016)

Snowballs and Icicles in Susac’s Syndrome
por: Dierickx, Jesper, et al.
Publicado: (2021)

Cholinergic Basal Forebrain Volumes Predict Gait Decline in Parkinson's Disease
por: Wilson, Joanna, et al.
Publicado: (2020)

Prevalence and duration of non‐motor symptoms in prodromal Parkinson's disease
por: Durcan, R., et al.
Publicado: (2019)

The Cerebrospinal Fluid Profile of Cholesterol Metabolites in Parkinson’s Disease and Their Association With Disease State and Clinical Features
por: Griffiths, William J., et al.
Publicado: (2021)

Early constipation predicts faster dementia onset in Parkinson’s disease
por: Camacho, M., et al.
Publicado: (2021)

The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease
por: White, Alice J., et al.
Publicado: (2018)

Monocyte Function in Parkinson's Disease and the Impact of Autologous Serum on Phagocytosis
por: Wijeyekoon, Ruwani S., et al.
Publicado: (2018)

Factors Influencing Habitual Physical Activity in Parkinson’s Disease: Considering the Psychosocial State and Wellbeing of People with Parkinson’s and Their Carers
por: Mc Ardle, Ríona, et al.
Publicado: (2022)

Free-water imaging of the cholinergic basal forebrain and pedunculopontine nucleus in Parkinson’s disease
por: Ray, Nicola J, et al.
Publicado: (2022)

B lymphocyte responses in Parkinson’s disease and their possible significance in disease progression
por: Scott, Kirsten M, et al.
Publicado: (2023)

Gait Progression Over 6 Years in Parkinson’s Disease: Effects of Age, Medication, and Pathology
por: Wilson, Joanna, et al.
Publicado: (2020)

Abnormalities of age-related T cell senescence in Parkinson’s disease
por: Williams-Gray, C. H., et al.
Publicado: (2018)

Reduced mitochondrial DNA copy number is a biomarker of Parkinson's disease
por: Pyle, Angela, et al.
Publicado: (2016)

Gait‐Related Metabolic Covariance Networks at Rest in Parkinson's Disease
por: Sigurdsson, Hilmar P., et al.
Publicado: (2022)

Variation in complement protein C1q is not a major contributor to cognitive impairment in Parkinson’s disease
por: Carbutt, Sophia, et al.
Publicado: (2015)

Cognition and Gait Show a Selective Pattern of Association Dominated by Phenotype in Incident Parkinson’s Disease
por: Lord, Sue, et al.
Publicado: (2014)

Coping with Cognitive Impairment in People with Parkinson's Disease and Their Carers: A Qualitative Study
por: Lawson, Rachael A., et al.
Publicado: (2018)

Cognitive follow up of a small cohort of Huntington’s disease patients over a 5 year period.
por: Mason, Sarah L, et al.
Publicado: (2010)

Natural history of falls in an incident cohort of Parkinson’s disease: early evolution, risk and protective features
por: Lord, Sue, et al.
Publicado: (2017)

metabolic profiling of Parkinson's disease and mild cognitive impairment
por: Burté, Florence, et al.
Publicado: (2017)

Smartphone- and internet-assisted self-management and adherence tools to manage Parkinson’s disease (SMART-PD): study protocol for a randomised controlled trial (v7; 15 August 2014)
por: Lakshminarayana, Rashmi, et al.
Publicado: (2014)

Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease
por: Breen, David P., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bnpq0tf1ac949a6r7gos4tg4jv